These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16125074)

  • 1. Evaluation of extracellular signal regulated kinase expression and its relation to treatment of hepatocellular carcinoma.
    Osada S; Kanematsu M; Imai H; Goshima S; Sugiyama Y
    J Am Coll Surg; 2005 Sep; 201(3):405-11. PubMed ID: 16125074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma.
    Osada S; Kanematsu M; Imai H; Goshima S
    Hepatogastroenterology; 2008; 55(82-83):544-9. PubMed ID: 18613405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma.
    Ito Y; Sasaki Y; Horimoto M; Wada S; Tanaka Y; Kasahara A; Ueki T; Hirano T; Yamamoto H; Fujimoto J; Okamoto E; Hayashi N; Hori M
    Hepatology; 1998 Apr; 27(4):951-8. PubMed ID: 9537433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
    Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
    Hepatology; 1997 Apr; 25(4):862-6. PubMed ID: 9096589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
    Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma.
    Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
    Hepatology; 1997 Mar; 25(3):619-23. PubMed ID: 9049208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer.
    Osada S; Matsui S; Komori S; Yamada J; Sanada Y; Ihawa A; Tanaka Y; Tokuyama Y; Okumura N; Nonaka K; Hosono Y; Takahashi T; Yamaguchi K; Yoshida K
    Hepatogastroenterology; 2010; 57(97):76-80. PubMed ID: 20422876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
    Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors.
    Yoshida T; Hisamoto T; Akiba J; Koga H; Nakamura K; Tokunaga Y; Hanada S; Kumemura H; Maeyama M; Harada M; Ogata H; Yano H; Kojiro M; Ueno T; Yoshimura A; Sata M
    Oncogene; 2006 Oct; 25(45):6056-66. PubMed ID: 16652141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: its specific receptor c-met does.
    D'Errico A; Fiorentino M; Ponzetto A; Daikuhara Y; Tsubouchi H; Brechot C; Scoazec JY; Grigioni WF
    Hepatology; 1996 Jul; 24(1):60-4. PubMed ID: 8707284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma.
    Calvisi DF; Pinna F; Meloni F; Ladu S; Pellegrino R; Sini M; Daino L; Simile MM; De Miglio MR; Virdis P; Frau M; Tomasi ML; Seddaiu MA; Muroni MR; Feo F; Pascale RM
    Cancer Res; 2008 Jun; 68(11):4192-200. PubMed ID: 18519678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlations of expressions of macrophage migration inhibitor factor and cyclin D1 with tumor size and metastasis of hepatocellular carcinoma].
    Xia JT; Li W; Liu YJ; Chen LZ; Wu ZF; Zhang LJ; Wang Q
    Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):918-21. PubMed ID: 18171527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
    Mazzanti R; Platini F; Bottini C; Fantappiè O; Solazzo M; Tessitore L
    Biochem Pharmacol; 2009 Jul; 78(1):21-32. PubMed ID: 19447220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma.
    Tsuboi Y; Ichida T; Sugitani S; Genda T; Inayoshi J; Takamura M; Matsuda Y; Nomoto M; Aoyagi Y
    Liver Int; 2004 Oct; 24(5):432-6. PubMed ID: 15482339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the c-met protooncogene in human hepatocellular carcinoma.
    Suzuki K; Hayashi N; Yamada Y; Yoshihara H; Miyamoto Y; Ito Y; Ito T; Katayama K; Sasaki Y; Ito A
    Hepatology; 1994 Nov; 20(5):1231-6. PubMed ID: 7927256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-met and hepatocyte growth factor expression in combined hepatocellular and cholangiocarcinoma.
    Varnholt H; Asayama Y; Aishima S; Taguchi K; Sugimachi K; Tsuneyoshi M
    Oncol Rep; 2002; 9(1):35-41. PubMed ID: 11748452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.